TP53 overexpression is an independent adverse prognostic factor in de novo myelodysplastic syndromes with fibrosis

Research output: Contribution to journalArticlepeer-review

37 Scopus citations

Fingerprint

Dive into the research topics of 'TP53 overexpression is an independent adverse prognostic factor in de novo myelodysplastic syndromes with fibrosis'. Together they form a unique fingerprint.

Medicine & Life Sciences